Tag: morbidity and mortality

Study: US maternal mortality rises 28% in 5 years, inequities persist

JAMA (healthcare publication) Network logo

Editor's Note Pregnancy-related deaths in the US rose sharply from 2018 to 2022, with rates 3.8 times higher among American Indian and Alaska Native women and 2.8 times higher among non-Hispanic Black women than among White women, according to a new study published April 9 in JAMA Network Open. Researchers…

Read More

By: Matt Danford
April 10, 2025
Share

Study: Mortality prediction models fail to recognize severe patient injuries

Editor's Note Machine learning (ML) models designed to predict patient mortality are falling short when it comes to identifying severe injuries that could lead to death, according to a March 27 report in TechTarget. The article focuses on research published in Nature Communications Medicine found that ML mortality prediction models…

Read More

By: Matt Danford
April 7, 2025
Share

FDA announces Class 1 recall for implantable ports

Editor's Note The US Food and Drug Administration (FDA) has deemed Smiths Medical’s recall of Proport Plastic Implantable Ports a Class 1, the most severe designation indicating serious risk of injury or death. The devices are designed for repeated venous access for injections, infusions, and/or blood samples. According to the…

Read More

By: Matt Danford
March 20, 2025
Share

FDA designates Class 1 recall for embolization devices

Editor's Note Endovascular devices used to block aneurysm blood flow are the subject of the latest recall to be designated Class 1—the most severe designation indicating serious risk of injury or death—by the US Food and Drug Administration (FDA). As detailed in the agency’s March 18 announcement, Medtronic Neurovascular is…

Read More

By: Matt Danford
March 19, 2025
Share

Study: CMS sepsis care protocol shows no clear mortality benefit

Editor's Note A systematic review found no strong evidence that compliance with the CMS Severe Sepsis and Septic Shock Management Bundle (SEP-1) reduces mortality, raising questions about its inclusion in hospital performance measures, according to a February 19 report from the University of Minnesota’s Center for Infectious Disease Research and…

Read More

By: Matt Danford
March 12, 2025
Share

FDA announces Class 1 endovascular system, anesthesia system recalls

Editor's Note The US Food and Drug Administration (FDA) designated Getinge’s recall of Vaporizer Sevoflurane Maquet Filling and Sevoflurane Quick-Fil and Philips’ recall of Tack Endovascular Systems as Class 1s, the most severe category indicating serious risk of injury or death. The Getinge recall is an expansion of a 2024…

Read More

By: Matt Danford
March 3, 2025
Share

Study highlights nurse staffing disparity in hospitals serving black populations

Editor's Note Nurse staffing rates in hospitals serving a high percentage of Black patients are worse than in hospitals serving fewer Black patients, a disparity that has significant implications for patient outcomes, according to a study from the University of Pennsylvania School of Nursing. Published in the journal Nursing Research…

Read More

By: Matt Danford
January 16, 2025
Share

Study: Black CABG patients disadvantaged in accessing best hospitals

Editor's Note Black patients are less likely to receive surgery at hospitals with the lowest mortality rates despite living closer to these facilities, according to a new study examining Medicare patients undergoing coronary artery bypass grafting (CABG) from 2017 to 2019. Authors suggest that physician referral patterns may play a…

Read More

By: Matt Danford
January 6, 2025
Share

Study: Advanced recovery room care could reduce long-term postoperative mortality

Editor's Note Findings from The ARRC II study show using advanced recovery room care (ARRC) for medium-risk surgical patients significantly reduces 18-month postoperative mortality compared to standard ward care. As detailed in a December 11 research letter in JAMA Surgery, this benefit appears linked to minimizing early postoperative complications, which…

Read More

By: Matt Danford
December 19, 2024
Share

FDA designates Class 1 recalls for balloon catheters, radiographic markers

Editor's Note Balloon catheters for atrial fibrillation patients and implantable radiographic markers were the subjects of separate US Food and Drug Administration (FDA) Class 1 recalls—the most severe category indicating risk of serious injury or death—announced on December 18. The first recall involves Boston Scientific’s POLARx Cryoablation devices. Higher-than-anticipated reports…

Read More

By: Matt Danford
December 19, 2024
Share

Join our community

Learn More
Video Spotlight
Live chat by BoldChat